Medifast, Inc.
MED
$10.53
$0.100.96%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -992.97% | -96.61% | -87.60% | -110.33% | -97.90% |
| Total Depreciation and Amortization | 12.08% | 8.44% | 4.67% | -4.99% | -3.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.62% | -95.90% | -88.78% | 65.91% | 30.72% |
| Change in Net Operating Assets | -0.62% | 40.56% | -74.63% | -106.20% | -148.06% |
| Cash from Operations | -71.96% | -81.99% | -93.17% | -77.33% | -83.42% |
| Capital Expenditure | 24.68% | -7.08% | -2.69% | -14.91% | -14.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 87.86% | -35.51% | 94.05% | 66.37% | 65.06% |
| Cash from Investing | 70.11% | -25.75% | 84.14% | 58.19% | 56.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -97.22% | -100.00% | -100.00% | -100.00% | -80.85% |
| Repurchase of Common Stock | 55.74% | 56.09% | 60.86% | 58.68% | 87.99% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 72.73% | 98.96% | 99.47% | 99.64% | 99.02% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 62.77% | 97.09% | 98.49% | 98.94% | 98.10% |
| Foreign Exchange rate Adjustments | -91.49% | 100.00% | 103.13% | 148.48% | 165.28% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 53.73% | -717.41% | 83.95% | 78.10% | -152.04% |